{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:01:17Z","timestamp":1791381677500,"version":"4.3.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["17SWO06"],"award-info":[{"award-number":["17SWO06"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is a progressive disease with high societal costs. CKD progression is influenced by patients\u2019 health literacy, i.e., the patients\u2019 ability to deal with information related to their own health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the cost-effectiveness of Grip on Your Kidneys (GoYK), a multi-component health literacy intervention for CKD patients and their healthcare professionals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and Main Measures<\/jats:title>\n                    <jats:p>We performed a cost-utility analysis of the GoYK intervention, measuring health outcomes in terms of quality-adjusted life years (QALYs) and costs in euros, and extrapolated the results to a lifetime horizon using a Markov model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects<\/jats:title>\n                    <jats:p>The GoYK study was a quasi-experimental study involving 147 patients with CKD and 48 healthcare professionals from Dutch general practices and nephrology clinics, followed over nine months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>We found that the GoYK intervention would yield a cost-saving of \u20ac28,616 and a gain of 0.37 QALYs per CKD patient across the life course. Moreover, GoYK would avert 31 deaths and 113 new dialyses per 1,000 patients in the first 10\u00a0years. These results mainly stemmed from the intervention effect on the transition to end-stage renal disease, where reductions of as little as 1% would already mean GoYK is cost-saving. The intervention remained cost-effective in multiple sensitivity and scenario analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GoYK might be a solution to slow CKD progression and, thereby, reduce CKD costs. Given these promising findings and the novelty of our study, further research should confirm our findings before broad implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-025-09697-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:14:36Z","timestamp":1752138876000},"page":"967-975","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Health Literacy Intervention Targeting Chronic Kidney Disease Patients and Healthcare Professionals is Cost-saving: Findings from the Netherlands"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8830-4687","authenticated-orcid":false,"given":"Matheus S. Gurgel","family":"do Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8807-3068","authenticated-orcid":false,"given":"Marco D.","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1784-1001","authenticated-orcid":false,"given":"Simon","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-0599","authenticated-orcid":false,"given":"Ofer","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjan J.","family":"Navis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-7523","authenticated-orcid":false,"given":"Sijmen A.","family":"Reijneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-4889","authenticated-orcid":false,"given":"Andrea F.","family":"de Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"4","key":"9697_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S2213-8587(16)00033-4","volume":"4","author":"R Vanholder","year":"2016","unstructured":"Vanholder R, Fouque D, Glorieux G, et al. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol. 2016;4(4):360-373.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"9697_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrneph.2017.63","volume":"13","author":"R Vanholder","year":"2017","unstructured":"Vanholder R, Annemans L, Brown E, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13(7):393-409.","journal-title":"Nat Rev Nephrol."},{"issue":"suppl 1","key":"9697_CR3","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1681\/ASN.V13suppl_1s37","volume":"13","author":"M Lysaght","year":"2002","unstructured":"Lysaght M. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13(suppl 1):S37-40.","journal-title":"J Am Soc Nephrol."},{"key":"9697_CR4","unstructured":"European Statistics. European Statistical Office of the European Union (EUROSTAT). Accessed Dec 2022, https:\/\/ec.europa.eu\/eurostat"},{"issue":"8","key":"9697_CR5","doi-asserted-by":"publisher","first-page":"e0220800","DOI":"10.1371\/journal.pone.0220800","volume":"14","author":"SM Mohnen","year":"2019","unstructured":"Mohnen SM, van Oosten MJM, Los J, et al. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data. PLoS One. 2019;14(8):e0220800.","journal-title":"PLoS One."},{"key":"9697_CR6","volume-title":"Action plan for the prevention and control of noncommunicable diseases in the WHO European region","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Action plan for the prevention and control of noncommunicable diseases in the WHO European region. Copenhagen, Denmark. 2016."},{"issue":"4","key":"9697_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1053\/j.ajkd.2015.09.020","volume":"67","author":"B Mihaylova","year":"2016","unstructured":"Mihaylova B, Schlackow I, Herrington W, et al. Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2016;67(4):576-584.","journal-title":"Am J Kidney Dis."},{"key":"9697_CR8","doi-asserted-by":"crossref","unstructured":"Kindig DA, Panzer AM, Nielsen-Bohlman L. Introduction. In: Health literacy: a prescription to end confusion. 1st ed.Washington DC, USA: National Academies Press; 2004.","DOI":"10.17226\/10883"},{"issue":"6","key":"9697_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/0272989X16638330","volume":"36","author":"LM Mackey","year":"2016","unstructured":"Mackey LM, Doody C, Werner EL, et al. Self-management skills in chronic disease management: what role does health literacy have? Med Decis Making. 2016;36(6):741-759.","journal-title":"Med Decis Making."},{"issue":"9","key":"9697_CR10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/ndt\/gfx293","volume":"33","author":"DM Taylor","year":"2017","unstructured":"Taylor DM, Fraser S, Dudley C, et al. Health literacy and patient outcomes in chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2017;33(9):1545-1558.","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"9697_CR11","first-page":"383","volume":"34","author":"MV Williams","year":"2002","unstructured":"Williams MV, Davis T, Parker RM, et al. The role of health literacy in patient-physician communication. Fam Med. 2002;34(5):383-389.","journal-title":"Fam Med."},{"issue":"9604","key":"9697_CR12","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/S0140-6736(07)61698-5","volume":"370","author":"P Asaria","year":"2007","unstructured":"Asaria P, Chisholm D, Mathers C, et al. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370(9604):2044-2053.","journal-title":"Lancet."},{"issue":"7445","key":"9697_CR13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/bmj.328.7445.947","volume":"328","author":"S Parrott","year":"2004","unstructured":"Parrott S, Godfrey C. Economics of smoking cessation. BMJ. 2004;328(7445):947\u2013949.","journal-title":"BMJ."},{"key":"9697_CR14","first-page":"1433","volume":"4","author":"J Guo","year":"1998","unstructured":"Guo J, Gibson J, Gropper D, et al. Empiric Investigation on Direct Costs-of-Illness and Healthcare. Am J Man Care. 1998;4:1433-46.","journal-title":"Am J Man Care."},{"issue":"9","key":"9697_CR15","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s40620-024-02058-8","volume":"37","author":"MD Boonstra","year":"2024","unstructured":"Boonstra MD, Gurgel do Amaral M, Navis G, et al. Effectiveness of a health literacy intervention targeting both chronic kidney disease patients and health care professionals in primary and secondary care: a quasi-experimental study. J Nephrol. 2024;37(9):2621-2633.","journal-title":"J Nephrol."},{"issue":"1","key":"9697_CR16","first-page":"1","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150.","journal-title":"Kidney Int Suppl"},{"key":"9697_CR17","unstructured":"Dutch National Health Care Institute [Zorginstituut Nederland]. Guideline for economic evaluations in healthcare. Diemen, The Netherlands. 2016."},{"issue":"7514","key":"9697_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/bmj.331.7514.446","volume":"331","author":"WBF Brouwer","year":"2005","unstructured":"Brouwer WBF, Niessen LW, Postma MJ, et al. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ. 2005;331(7514):446-448.","journal-title":"BMJ."},{"key":"9697_CR19","unstructured":"Hakkaart-van Roijen L, van der Lindenc N, Bouwmans C, et al. Dutch National Health Care Institute [Zorginstituut Nederland]. Cost manual: Methodology of cost research and reference prices for economic evaluations in healthcare [Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg]. Diemen, The Netherlands. 2016."},{"issue":"4","key":"9697_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/pmed.1995.1062","volume":"24","author":"PJ Elmer","year":"1995","unstructured":"Elmer PJ, Grimm R, Laing B, et al. Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). Prev Med. 1995;24(4):378-388.","journal-title":"Prev Med."},{"key":"9697_CR21","unstructured":"Leading causes of death. Statistics Netherlands (CBS). Accessed Jan 2022, https:\/\/www.cbs.nl\/"},{"issue":"5","key":"9697_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2010.39","volume":"303","author":"BR Hemmelgarn","year":"2023","unstructured":"Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation Between Kidney Function, Proteinuria, and Adverse Outcomes. JAMA. 2023;303(5):423-429.","journal-title":"JAMA."},{"key":"9697_CR23","unstructured":"Nefrodata. Nefrovisie. Accessed Jan 2023, https:\/\/www.nefrovisie.nl\/nefrodata\/"},{"key":"9697_CR24","unstructured":"Academic Medical Center, Department of Medical Informatics. ERA-EDTA Registry Annual Report 2014. Amsterdam, the Netherlands. 2016."},{"issue":"1","key":"9697_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12955-016-0577-5","volume":"15","author":"M Mangen","year":"2017","unstructured":"Mangen M, Bolkenbaas M, Huijts S, et al. Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L. Health Qual Life Outcomes. 2017;15(1):3.","journal-title":"Health Qual Life Outcomes."},{"issue":"4","key":"9697_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1524-4733.2007.00308.x","volume":"11","author":"Y Liem","year":"2008","unstructured":"Liem Y, Bosch J, Hunink M. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008;11(4):733-741.","journal-title":"Value Health."},{"key":"9697_CR27","unstructured":"Dutch guideline for chronic kidney disease (CKD) [Nederlandse richtlijn chronische nierziekte]. Institute of the Federation of Medical Specialists [Federatie Medisch Specialisten]. Accessed Jan, 2023, https:\/\/richtlijnendatabase.nl\/richtlijn\/chronische_nierschade_cns"},{"key":"9697_CR28","unstructured":"National Health Service (NHS). Chronic Kidney Disease in England: The Human and Financial Cost. United Kingdom. 2017. Better Kidney Care for All."},{"issue":"3","key":"9697_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2165\/11586130-000000000-00000","volume":"29","author":"PHM Van Baal","year":"2011","unstructured":"Van Baal PHM, Wong A, Slobbe LCJ, et al. Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations. Pharmacoeconomics. 2011;29(3):175-187.","journal-title":"Pharmacoeconomics."},{"key":"9697_CR30","unstructured":"Consumer price index. Statistics Netherlands (CBS). Accessed Dec 2022, https:\/\/www.cbs.nl\/en-gb\/figures\/detail\/83131eng"},{"key":"9697_CR31","doi-asserted-by":"crossref","unstructured":"Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford University Press; 2006.","DOI":"10.1093\/oso\/9780198526629.001.0001"},{"issue":"1","key":"9697_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jval.2021.08.003","volume":"25","author":"M Schurer","year":"2022","unstructured":"Schurer M, Matthijsse SM, Vossen CY, et al. Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands. Value Health. 2022;25(1):91-103.","journal-title":"Value Health."},{"key":"9697_CR33","volume-title":"Global Burden of Disease Study 2019 - Disability Weights","author":"GBD Collaborative Network","year":"2020","unstructured":"GBD Collaborative Network. Global Burden of Disease Study 2019 - Disability Weights. Seattle, USA. 2020."},{"issue":"10","key":"9697_CR34","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.3390\/ijerph18105235","volume":"18","author":"M GurgeldoAmaral","year":"2021","unstructured":"Gurgel do Amaral M, Reijneveld SA, Almansa J, et al. Do Uncontrolled Hypertension, Diabetes, Dyslipidemia, and Obesity Mediate the Relationship Between Health Literacy and Chronic Kidney Disease Complications? Int J Environ Res Public Health. 2021;18(10):5235.","journal-title":"Int J Environ Res Public Health."},{"issue":"2\u20133","key":"9697_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000350142","volume":"37","author":"CC Adarkwah","year":"2013","unstructured":"Adarkwah CC, Gandjour A, Akkerman M, et al. To Treat or Not to Treat? Cost-Effectiveness of Ace Inhibitors in Non-Diabetic Advanced Renal Disease - a Dutch Perspective. Kidney Blood Press Res. 2013;37(2-3):168-180.","journal-title":"Kidney Blood Press Res."},{"issue":"4","key":"9697_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0272-6386(97)90334-6","volume":"29","author":"A Levin","year":"1997","unstructured":"Levin A, Lewis M, Mortiboy P, et al. Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis. 1997;29(4):533-540.","journal-title":"Am J Kidney Dis."},{"key":"9697_CR37","unstructured":"Cost of diseases 2019. National Institute for Health and Environment (RIVM). Accessed Dec 2022, https:\/\/statline.rivm.nl\/"},{"issue":"1","key":"9697_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.ajkd.2015.12.019","volume":"68","author":"D Dunkler","year":"2016","unstructured":"Dunkler D, Kohl M, Teo K, et al. Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study. Am J Kidney Dis. 2016;68(1):29-40.","journal-title":"Am J Kidney Dis."},{"key":"9697_CR39","unstructured":"Drummond M, Sculpher M, Claxton K, et al. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford Medical Publications. Oxford University Press; 2015."},{"issue":"6","key":"9697_CR40","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","volume":"20","author":"R Vanholder","year":"2005","unstructured":"Vanholder R, Massy Z, Argiles A, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20(6):1048-1056.","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"9697_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514-525.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9731","key":"9697_CR42","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushitax","year":"2010","unstructured":"Matsushitax K, van der Velde M, Astor B, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-2081.","journal-title":"Lancet."},{"issue":"3","key":"9697_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s40620-022-01476-w","volume":"36","author":"M Alma","year":"2023","unstructured":"Alma M, van der Mei S, Brouwer S, et al. Sustained employment, work disability and work functioning in CKD patients: a cross-sectional survey study. J Nephrol. 2023;36(3):731-743.","journal-title":"J Nephrol."},{"issue":"1","key":"9697_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.ajkd.2014.07.033","volume":"65","author":"A Bello","year":"2015","unstructured":"Bello A, Levin A, Manns B, et al. Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis. 2015;65(1):15-25.","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"9697_CR45","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jama.2009.51","volume":"301","author":"S Woolf","year":"2009","unstructured":"Woolf S. A closer look at the economic argument for disease prevention. JAMA. 2009;301(5):536-538.","journal-title":"JAMA."},{"issue":"1","key":"9697_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amepre.2006.03.012","volume":"31","author":"M Maciosek","year":"2006","unstructured":"Maciosek M, Edwards N, Coffield A, et al. Priorities among effective clinical preventive services: methods. Am J Prev Med. 2006;31(1):52-61.","journal-title":"Am J Prev Med."},{"issue":"3","key":"9697_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/PSY.0000000000000556","volume":"80","author":"CHL Thio","year":"2018","unstructured":"Thio CHL, van Roon AM, Lefrandt JD, et al. Heart Rate Variability and Its Relation to Chronic Kidney Disease: Results From the PREVEND Study. Psychosom Med. 2018;80(3):307-316.","journal-title":"Psychosom Med."},{"issue":"3","key":"9697_CR48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11255-013-0563-3","volume":"46","author":"JC Van Blijderveen","year":"2014","unstructured":"Van Blijderveen JC, Straus SM, Zietse R, et al. A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands. Int Urol Nephrol. 2014;46(3):583-592.","journal-title":"Int Urol Nephrol."},{"issue":"21","key":"9697_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14210","volume":"14","author":"C Black","year":"2010","unstructured":"Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1-184.","journal-title":"Health Technol Assess."},{"issue":"6","key":"9697_CR50","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1053\/j.ajkd.2010.06.010","volume":"56","author":"R Hoefield","year":"2010","unstructured":"Hoefield R, Kalra P, Baker P, et al. Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis. 2010;56(6):1072-1081.","journal-title":"Am J Kidney Dis."},{"issue":"8","key":"9697_CR51","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1093\/ndt\/gfs054","volume":"27","author":"A Kanno","year":"2012","unstructured":"Kanno A, Kikuya M, Ohkubo T, et al. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study. Nephrol Dial Transplant. 2012;27(8):3218-3223.","journal-title":"Nephrol Dial Transplant."},{"issue":"12","key":"9697_CR52","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41440-021-00723-0","volume":"44","author":"C Kim","year":"2021","unstructured":"Kim C, Kim B, Choi H, et al. Cumulative hypertension burden and risk of end-stage renal disease. Hypertens Res. 2021;44(12):1652\u20131661.","journal-title":"Hypertens Res."},{"key":"9697_CR53","unstructured":"Annual figures for disorders - General practitioner registrations. Netherlands Institute for Health Care Research. Accessed Dec 2022, https:\/\/www.nivel.nl\/nl\/nivel-zorgregistraties-eerste-lijn\/jaarcijfers-aandoeningen-huisartsenregistraties"},{"key":"9697_CR54","unstructured":"Public health and care information. National Institute for Health and Environment (RIVM). Accessed Dec 2022, https:\/\/www.vzinfo.nl\/"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09697-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:25:45Z","timestamp":1774283145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09697-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["9697"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09697-y","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"GJ Navis reports being a member of the Health Council of the Netherlands and of the Advisory Board for Prevention of the Ministry of Health of the Netherlands. All remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate Declarations:"}}]}}